FTC sues significant pharmacy gain administrators over insulin rates The agency brought motion versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list cost of lifestyle-saving insulin drugs. Before this summer season, the company held prolonged negotiations with Steward about how to https://lanephyul.blogacep.com/35846119/healthcare-news-an-overview